Naarden Jacob Van - Net Worth and Insider Trading
Naarden Jacob Van Net Worth
The estimated net worth of Naarden Jacob Van is at least $5 Million dollars as of 2023-10-01. Naarden Jacob Van is the Chief Business Officer of Loxo Oncology Inc and owns about 20,700 shares of Loxo Oncology Inc (LOXO) stock worth over $5 Million. Details can be seen in Naarden Jacob Van's Latest Holdings Summary section.
Transaction Summary of Naarden Jacob Van
Naarden Jacob Van Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Naarden Jacob Van owns 1 companies in total, including Eli Lilly and Co (LLY) .
Click here to see the complete history of Naarden Jacob Van’s form 4 insider trades.
Insider Ownership Summary of Naarden Jacob Van
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LLY | Eli Lilly and Co | 2021-09-05 | SVP & CEO LoxoONC & Pres LlyONC |
Naarden Jacob Van Latest Holdings Summary
Naarden Jacob Van currently owns a total of 1 stock. Naarden Jacob Van owns 20,700 shares of Loxo Oncology Inc (LOXO) as of December 11, 2018, with a value of $5 Million.
Latest Holdings of Naarden Jacob Van
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LOXO | Loxo Oncology Inc | 2018-12-11 | 20,700 | 234.66 | 4,857,462 |
Holding Weightings of Naarden Jacob Van
Naarden Jacob Van Form 4 Trading Tracker
According to the SEC Form 4 filings, Naarden Jacob Van has made a total of 3 transactions in Loxo Oncology Inc (LOXO) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Loxo Oncology Inc is the sale of 9,000 shares on December 11, 2018, which brought Naarden Jacob Van around $1 Million.
Insider Trading History of Naarden Jacob Van
- 1
Naarden Jacob Van Trading Performance
Naarden Jacob Van Ownership Network
Ownership Network List of Naarden Jacob Van
Ownership Network Relation of Naarden Jacob Van
Naarden Jacob Van Owned Company Details
What does Eli Lilly and Co do?
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Who are the key executives at Eli Lilly and Co?
Naarden Jacob Van is the SVP & CEO LoxoONC & Pres LlyONC of Eli Lilly and Co. Other key executives at Eli Lilly and Co include EVP & HR & Diversity Eric Dozier , SVP & ERM & CECO Alonzo Weems , and SVP & CIDO Diogo Rau .
Eli Lilly and Co (LLY) Insider Trades Summary
Over the past 18 months, Naarden Jacob Van made no insider transaction in Eli Lilly and Co (LLY). Other recent insider transactions involving Eli Lilly and Co (LLY) include a net sale of 5,266,441 shares made by Lilly Endowment Inc , a net sale of 3,800 shares made by Donald A Zakrowski , and a net sale of 3,460 shares made by Alonzo Weems .
In summary, during the past 3 months, insiders sold 1,046,748 shares of Eli Lilly and Co (LLY) in total and bought 0 shares, with a net sale of 1,046,748 shares. During the past 18 months, 5,284,701 shares of Eli Lilly and Co (LLY) were sold and 656 shares were bought by its insiders, resulting in a net sale of 5,284,045 shares.
Eli Lilly and Co (LLY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eli Lilly and Co Insider Transactions
Naarden Jacob Van Mailing Address
Above is the net worth, insider trading, and ownership report for Naarden Jacob Van. You might contact Naarden Jacob Van via mailing address: C/o Eli Lilly & Co, Lilly Corporate Center, Indianapolis In 46285.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
